SPARC and cholangiocarcinoma: Another study suggested that TEVs delivered miR-210 to CCA cells, where miR-210 specifically decreased reversion-inducing cysteine-rich protein with kazal motif (RECK) expression, which ultimately facilitated growth, metastasis, and chemoresistance in CCA (78).